Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.

Wadey RM, Pinches MG, Jones HB, Riccardi D, Price SA.

Toxicol Pathol. 2014;42(3):591-602. doi: 10.1177/0192623313492044. Epub 2013 Jul 3.

PMID:
23823703
2.

Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.

Pinches M, Betts C, Bickerton S, Burdett L, Thomas H, Derbyshire N, Jones HB, Moores M.

Toxicol Pathol. 2012 Apr;40(3):522-33. doi: 10.1177/0192623311432438.

PMID:
22491933
3.

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.

Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV.

Am J Physiol Renal Physiol. 2004 Mar;286(3):F552-63. Epub 2003 Nov 4.

4.

Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.

Vinken P, Starckx S, Barale-Thomas E, Looszova A, Sonee M, Goeminne N, Versmissen L, Buyens K, Lampo A.

Toxicol Pathol. 2012 Oct;40(7):1049-62. Epub 2012 May 11.

PMID:
22581811
5.

Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.

Bulacio RP, Torres AM.

Arch Toxicol. 2013 Nov;87(11):1953-62. doi: 10.1007/s00204-013-1062-0. Epub 2013 May 7.

PMID:
23649842
6.

Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.

Vlasakova K, Erdos Z, Troth SP, McNulty K, Chapeau-Campredon V, Mokrzycki N, Muniappa N, Gu YZ, Holder D, Bailey WJ, Sistare FD, Glaab WE.

Toxicol Sci. 2014 Mar;138(1):3-20. doi: 10.1093/toxsci/kft330. Epub 2013 Dec 21.

PMID:
24361871
7.

Time course of renal proximal tubule injury, reversal, and related biomarker changes in rats following cisplatin administration.

McDuffie JE, Ma JY, Sablad M, Sonee M, Varacallo L, Louden C, Guy A, Vegas J, Liu X, La D, Snook S.

Int J Toxicol. 2013 Jul;32(4):251-60. doi: 10.1177/1091581813493013. Epub 2013 Jun 20.

PMID:
23788329
8.

Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury.

Nan-Ya K, Kajihara M, Kojima N, Degawa M.

J Appl Toxicol. 2015 Feb;35(2):124-32. doi: 10.1002/jat.2999. Epub 2014 Apr 16.

PMID:
24737228
9.

Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model.

Carlos CP, Sonehara NM, Oliani SM, Burdmann EA.

PLoS One. 2014 Jul 29;9(7):e103660. doi: 10.1371/journal.pone.0103660. eCollection 2014.

10.

Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.

Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL.

Toxicol Sci. 2008 Jan;101(1):159-70. Epub 2007 Oct 13.

11.

Age-related differences in kidney injury biomarkers induced by cisplatin.

Shin YJ, Kim TH, Won AJ, Jung JY, Kwack SJ, Kacew S, Chung KH, Lee BM, Kim HS.

Environ Toxicol Pharmacol. 2014 May;37(3):1028-39. doi: 10.1016/j.etap.2014.03.014. Epub 2014 Mar 26.

PMID:
24751685
12.

Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.

Harpur E, Ennulat D, Hoffman D, Betton G, Gautier JC, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M, Shaw M, Lock E, Pettit S; HESI Committee on Biomarkers of Nephrotoxicity..

Toxicol Sci. 2011 Aug;122(2):235-52. doi: 10.1093/toxsci/kfr112. Epub 2011 May 18.

PMID:
21593213
13.

Evaluation of novel urinary renal biomarkers: biological variation and reference change values.

Pinches MD, Betts CJ, Bickerton SJ, Beattie L, Burdett LD, Thomas HT, Derbyshire NA, Moores M, Price SA.

Toxicol Pathol. 2012 Apr;40(3):541-9. doi: 10.1177/0192623311432436. Epub 2012 Mar 6.

PMID:
22395790
14.

Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.

Hosohata K, Ando H, Fujimura A.

J Pharmacol Exp Ther. 2012 Jun;341(3):656-62. doi: 10.1124/jpet.112.192807. Epub 2012 Mar 7.

15.

Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.

Pavkovic M, Riefke B, Gutberlet K, Raschke M, Ellinger-Ziegelbauer H.

J Pharmacol Toxicol Methods. 2014 Mar-Apr;69(2):196-204. doi: 10.1016/j.vascn.2013.11.003. Epub 2013 Dec 12.

PMID:
24333954
16.

Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats.

Tonomura Y, Tsuchiya N, Torii M, Uehara T.

Toxicology. 2010 Jun 29;273(1-3):53-9. doi: 10.1016/j.tox.2010.04.015. Epub 2010 May 10.

PMID:
20438795
17.

Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.

Hoffmann D, Fuchs TC, Henzler T, Matheis KA, Herget T, Dekant W, Hewitt P, Mally A.

Toxicology. 2010 Nov 9;277(1-3):49-58. doi: 10.1016/j.tox.2010.08.013. Epub 2010 Sep 9.

PMID:
20816719
18.

Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.

Kanki M, Moriguchi A, Sasaki D, Mitori H, Yamada A, Unami A, Miyamae Y.

Toxicology. 2014 Oct 3;324:158-68. doi: 10.1016/j.tox.2014.05.004. Epub 2014 May 24.

PMID:
24863737
19.

Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.

Rouse RL, Stewart SR, Thompson KL, Zhang J.

Toxicol Pathol. 2013;41(4):662-80. doi: 10.1177/0192623312464122. Epub 2012 Oct 19.

PMID:
23085980
20.

Change in kidney damage biomarkers after 13 weeks of exposing rats to the complex of Paecilomyces sinclairii and its host Bombyx mori larvae.

Jeong M, Kim YW, Min JR, Kwon M, Han BS, Kim JG, Jeong SH.

Food Chem Toxicol. 2013 Sep;59:177-86. doi: 10.1016/j.fct.2013.05.041. Epub 2013 Jun 6.

PMID:
23747716

Supplemental Content

Support Center